For the Inventor, By the Inventor

Enter assignee name

Leuven, Belgium

Stichting Rega Vzw

USPTO Granted Patents = 16

Forward Citations = 218

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Erik D De Clercq (12 out of 22 patents)

Antonin Holy (3 out of 12 patents)

Masanori Baba (2 out of 37 patents)

4. Piet A Herdewijn (2 out of 3 patents)

5. Masaaki Iigo (2 out of 2 patents)

6. Miklos Low (2 out of 5 patents)

7. Miklos Nagy (2 out of 4 patents)

8. Sandor Gorog (2 out of 37 patents)

9. Sandorne Gyorgyi (2 out of 2 patents)

10. Arthur Albert Van Aerschot (2 out of 2 patents)

11. Samuel Broder (1 out of 13 patents)

12. Paul Proost (1 out of 6 patents)

13. Jo Van Damme (1 out of 6 patents)

14. Jan M Balzarini (1 out of 2 patents)

15. Richard T Walker (1 out of 9 patents)

16 patents: Sort by Forward Citations

1. 5840524 - Granulocyte chemotactic protein (1998-11-24),

2. 5668113 - Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral (1997-09-16),

3. 5607922 - 1,5-anhydrohexitol nucleoside analogues (1997-03-04),

4. 5292505 - Sulphated vinyl polymer in composition for treating retroviral infections (1994-03-08),

5. 5152978 - Sulphated vinyl polymers in compositions for treating retroviral (1992-10-06),

6. 5137724 - Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic (1992-08-11),

7. 5116822 - Therapeutic application of dideoxycytidinene (1992-05-26),

8. 4988678 - Combinations of FU and BVU as anti-adenocarcinoma agents (1991-01-29),

9. 4894365 - Combinations of FU and BVU as anti-adenocarcinoma agents (1990-01-16),

10. 4724233 - Therapeutical application of phosphonylmethoxyalkyl adenines (1988-02-09),

11. 4605658 - Antivirally active adenine derivatives (1986-08-12),

12. 4382925 - E-5-(2-Halogenovinyl)-2'-deoxycytidines (1983-05-10),

13. 4359389 - Method for the purification of interferon (1982-11-16),

14. 4230708 - Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine (1980-10-28),

15. 4168261 - Method for the purification of interferon using porous glass beads (1979-09-18),

Company Overview

Stichting Rega Vzw, based in Leuven, Belgium, is a prominent research organization focused on advancing medical technologies and therapies. It specializes in the development of innovative solutions in the fields of infectious diseases, immunology, and regenerative medicine. The organization collaborates with various academic and industrial partners to translate scientific discoveries into practical applications, aiming to improve patient outcomes and enhance healthcare delivery. Its commitment to research excellence positions it as a key player in the European biomedical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

16 Patents

#11 in Leuven

#190 in Belgium

#37,868 in the World

Leuven, Belgium

Stichting Rega Vzw

Forward Citations = 218

24 inventors:

Erik D De Clercq (12 out of 22 patents)

Antonin Holy (3 out of 12 patents)

Masanori Baba (2 out of 37 patents)

4. Piet A Herdewijn (2 out of 3 patents)

5. Masaaki Iigo (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Stichting Rega Vzw. Retrieved from https://idiyas.com/company/stichting-rega-vzw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…